Liver fibrosis is the buildup of scar tissue in the liver, caused by repeated or ongoing damage. When the liver is injured, whether by alcohol, viral infections, or excess fat, it tries to repair itself by producing tough, fibrous proteins like collagen. Over time, this scar tissue accumulates and begins to replace healthy liver tissue, gradually disrupting the organ’s structure and function. Fibrosis is not a disease on its own but a consequence of other liver conditions, and it progresses through measurable stages from mild scarring to cirrhosis.
How Scar Tissue Forms in the Liver
The scarring process centers on a specific type of cell called a hepatic stellate cell. In a healthy liver, these cells sit quietly between other liver cells and mostly store vitamin A. When the liver is injured, inflammatory signals wake them up and transform them into a completely different cell type: one that behaves like a wound-healing machine, pumping out collagen and other structural proteins. These activated cells are responsible for roughly 80% of the fibrous collagen found in a scarred liver.
A growth factor called TGF-beta is one of the main drivers of this process, triggering a chain reaction inside stellate cells that ramps up collagen production. As long as the injury continues, whether from ongoing alcohol use, an untreated viral infection, or chronic inflammation from fatty liver disease, these cells keep laying down scar tissue. The result is a progressive remodeling of the liver’s internal architecture, which eventually interferes with blood flow through the organ and reduces its ability to filter toxins, produce proteins, and process nutrients.
What Causes Liver Fibrosis
Fatty liver disease (now often called metabolic dysfunction-associated steatotic liver disease) has become the most common cause of chronic liver disease worldwide, affecting at least 25% of the global adult population. In a Romanian population-based study that screened for significant fibrosis, nearly half of those with meaningful scarring had fatty liver disease as the underlying cause. Alcohol-related liver disease and chronic hepatitis B and C infections accounted for most of the remaining cases, with roughly equal contributions.
Less common causes include autoimmune hepatitis, where the immune system attacks liver cells, and iron overload conditions like hemochromatosis. Certain medications, bile duct disorders, and inherited metabolic diseases can also trigger fibrosis over time. In many cases, people have more than one contributing factor, such as moderate alcohol use combined with obesity, which accelerates the scarring process.
Stages of Fibrosis
Doctors grade liver fibrosis on a scale from F0 to F4. F0 means no fibrosis at all. F1 indicates mild scarring, typically limited to small areas around blood vessels in the liver. F2 represents moderate fibrosis, where scar tissue has started to extend outward and form bridges between different parts of the liver. F3 is advanced fibrosis with extensive bridging, and F4 is cirrhosis, where scar tissue has fundamentally distorted the liver’s structure and formed thick bands that divide the organ into abnormal nodules.
The progression from one stage to the next is not predictable or uniform. Studies using paired liver biopsies have found that 16% to 30% of people with severe fibrosis (F3) progress to cirrhosis over varied follow-up periods. Some people remain stable at the same stage for years, while others progress more quickly depending on the underlying cause, genetics, and lifestyle factors like continued alcohol use or weight gain.
Why Early Fibrosis Causes No Symptoms
Liver fibrosis itself typically causes no symptoms, especially in the early and moderate stages. The liver has enormous functional reserve, meaning it can keep doing its job even when a significant portion has been replaced by scar tissue. Many people with fibrosis feel completely well and only discover the problem when blood tests or imaging done for an unrelated reason reveal abnormalities.
When symptoms do appear, they usually reflect the underlying condition causing the damage rather than the scarring itself. Someone with fatty liver disease might feel fatigued or notice vague discomfort in the upper right abdomen, but this is from the inflammation, not the fibrosis. Symptoms that specifically signal worsening liver function, like yellowing of the skin and eyes (jaundice) or fluid accumulation in the abdomen (ascites), generally don’t show up until fibrosis has progressed to advanced stages or cirrhosis.
How Fibrosis Is Detected
Because fibrosis is silent for so long, doctors rely on screening tools rather than waiting for symptoms. The simplest first step is a blood-based score called the FIB-4 index, which combines your age, platelet count, and two liver enzymes (AST and ALT) into a single number. A FIB-4 score below 1.30 is reassuring and generally rules out advanced fibrosis. Higher scores prompt further testing.
The next step is usually transient elastography, a painless ultrasound-based scan that measures liver stiffness. Stiffer tissue means more scarring. A reading below 8.0 kilopascals (kPa) puts you in the low-risk category for advanced fibrosis. Readings between 8.0 and 12.0 kPa fall into an intermediate zone that needs further evaluation. Above 12 to 15 kPa strongly suggests advanced fibrosis, and readings of 20 kPa or higher can confirm cirrhosis without a biopsy, with about 95% specificity.
Liver biopsy, where a small needle removes a tiny sample of tissue for examination under a microscope, remains the most detailed way to assess fibrosis. It allows pathologists to see the exact pattern and extent of scarring. But because it’s invasive and carries a small risk of complications, it’s increasingly reserved for cases where non-invasive tests give unclear or conflicting results.
Fibrosis Can Be Reversed
One of the most important things to know about liver fibrosis is that it is not necessarily permanent. Clinical evidence has consistently shown that fibrosis can regress when the underlying cause of liver injury is removed. This was once considered unlikely, but studies across multiple liver diseases have confirmed it.
The evidence is strongest for viral hepatitis. Between 51% and 88% of people with hepatitis B-related fibrosis achieve regression after long-term suppression of the virus. Fibrosis from hepatitis C similarly improves after the virus is eradicated with antiviral treatment. In one study, even portal hypertension (high blood pressure in liver vessels, a hallmark of advanced disease) improved in 18 out of 19 patients with hepatitis B-related cirrhosis after 12 months of antiviral therapy, suggesting that the vascular changes caused by scarring can also partially reverse.
Reversal has been documented in other conditions too. People with alcoholic liver disease can see fibrosis regress after stopping alcohol consumption. Those with fatty liver disease show improvement after weight loss through lifestyle changes or bariatric surgery. Patients with autoimmune hepatitis tend to see regression once biochemical remission is achieved, and people with hemochromatosis can move from severe to milder fibrosis stages with effective treatment.
That said, reversal has limits. The more advanced the fibrosis, and the longer it has been present, the harder it is to fully undo. Cirrhosis can partially improve, but the liver may not return to a completely normal architecture. Early detection and treatment of the underlying cause give the liver the best chance of meaningful recovery.